Coronary-Artery Stents

Author:
  • MSMark E Silverman
    Mark E Silverman

Abstract
I am troubled by the universal enthusiasm displayed by interventional cardiologists for coronary-artery stenting — stent mania. As mentioned by Serruys et al. in their excellent review (Feb. 2 issue),1 “stenting [with bare metal stents] reduces restenosis and repeated intervention, but does not reduce mortality or myocardial infarction,” as compared with angioplasty alone. This failure to improve prognosis is also true for drug-eluting stents. However, life-threatening, in-stent thrombosis does present a serious early and late risk — and one that increases greatly if antiplatelet drugs are stopped. Antiplatelet regimens that are required in such cases not only are expensive but pose a major dilemma if noncardiac surgery or procedures become necessary. Systemic hypersensitivity reactions to stents, the improper positioning or dislodgment of stents, and delayed restenosis have been reported. What else may be in the offing? For angina, I believe I would prefer to have just plain old balloon angioplasty, rather than a bare metal or drug-eluting stent, with their uncertain future risk, irrevocably stuffed into my coronary artery. Because restenosis usually presents with angina, the culprit area can be successfully redilated.